aptoll
Small moleculeexperimental
Clinical trial activity
4 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 18, 2019 (NCT04742062)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Toll-like receptor 4ANTAGONIST
TLR4 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05569720 | Phase 1 | Apr 25, 2022 | aptaTargets S.L., Universidad Autonoma de Madrid |
| NCT05293236 | Phase 1 | Jan 14, 2022 | aptaTargets S.L., Universidad Autonoma de Madrid, Universidad Complutense de Madrid |
| NCT04734548 | Phase 1/Phase 2 (Phase 2) | Oct 28, 2020 | Anagram, aptaTargets S.L., Government of Spain |
| NCT04742062 | Phase 1 | Jul 18, 2019 | Anagram, aptaTargets S.L., Government of Spain, Universidad Autonoma de Madrid |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| aptaTargets S.L. | For profit | 4 | 4 | 2 | 2019 |
| Universidad Autonoma de Madrid | Academic/Hospital | 3 | 0 | 1 | 2019 |
| Anagram | For profit | 2 | 0 | 2 | 2019 |
| Government of Spain | Government | 2 | 0 | 2 | 2019 |
| Universidad Complutense de Madrid | Academic/Hospital | 1 | 0 | 1 | 2022 |
5 organizations
Page 1 / 1